A project from the American Society of Retina Specialists
Sign in to view content
Effect of Fluocinolone Acetonide 0.2µg/day (ILUVIEN®) Implant on the Decision to Drive in Patients With Differential Control of DME
- Video
- Published 2018
Related
Category: Diabetic Retinopathy